Phenylbutazone (CID 4781) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(46)
 
 
Inactive(1203)
 
 
Inconclusive(213)
 
 
Unspecified(1766)
 
 
Top Targets:
7TM GPCR Srx(36)
 
 
 
 
7TM GPCR Srsx(20)
 
 
 
NR LBD PPAR(16)
 
 
 
Tryp SPc(14)
 
 
 
NR LBD TR(14)
 
 
 
BioAssay Types:
Confirmatory(644)
 
 
 
 
 
Screening(554)
 
 
 
Literature(396)
 
 
 
 
 
Summary(2)
 
 
 
BioActivity Types:
Potency(510)
 
 
 
 
 
IC50(188)
 
 
 
 
 
EC50(11)
 
 
Ki(4)
 
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 2824    Data Row: 3228   Total Pages: 65   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103175225]
IC50 3Compound was evaluated for inhibition of Prostaglandin G/H synthase 1 [AID162309, Type: other]
View
2
[SID855958]
Potency 3.2944Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory]
View
3
[SID103175225]
IC50 3.79Inhibitory activity of the compound against canine COX-2 [AID220492, Type: Literature]Prostaglandin G/H synthase-2 [gi:75047671]
View
4
[SID90341773]
Potency 10qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory]euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070]
View
5
[SID103175225]
IC50 10Antiplasmodial activity against Plasmodium falciparum 3D7 after 72 hrs by SYBR green assay [AID524790, Type: Literature]
View
6
[SID103175225]
IC50 10Inhibition of PGH synthase in tissues with lower lipid peroxide concentrations [AID155368, Type: Literature]Prostaglandin G/H synthase 2 [gi:3914304]
View
7
[SID50104199]
Potency 11.2202qHTS for differential inhibitors of proliferation of Plasmodium falciparum line 3D7 [AID1876, Type: confirmatory]
View
8
[SID50104199]
Potency 11.2202qHTS for differential inhibitors of proliferation of Plasmodium falciparum line W2 [AID1883, Type: confirmatory]
View
9
[SID103175225]
IC50 12.5892Antiplasmodial activity against Plasmodium falciparum 7G8 after 72 hrs by SYBR green assay [AID524791, Type: Literature]
View
10
[SID103175225]
IC50 12.5892Antiplasmodial activity against Plasmodium falciparum D10 after 72 hrs by SYBR green assay [AID524792, Type: Literature]
View
11
[SID103175225]
IC50 12.5892Antiplasmodial activity against Plasmodium falciparum GB4 after 72 hrs by SYBR green assay [AID524794, Type: Literature]
View
12
[SID103175225]
IC50 12.5892Antiplasmodial activity against Plasmodium falciparum HB3 after 72 hrs by SYBR green assay [AID524795, Type: Literature]
View
13
[SID103175225]
IC50 12.5892Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay [AID524796, Type: Literature]
View
14
[SID104171220]
Potency 13.4591Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory]
View
15
[SID50104199]
Potency 14.1254qHTS for differential inhibitors of proliferation of Plasmodium falciparum line GB4 [AID1816, Type: confirmatory]
View
16
[SID103175225]
IC50 15Compound was tested for inhibition of prostaglandin synthetase when administered perorally [AID160905, Type: Literature]
View
17
[SID103175225]
Ki 19Binding affinity towards cytochrome P450 2C9 [AID54410, Type: Literature]
View
18
[SID103175225]
ED50 32.4In vivo effective dose required for antiinflammatory activity in rat adjuvant arthritis model [AID177164, Type: Literature]
View
19
[SID26751573]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_57, Type: Literature]
View
20
[SID26751573]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_32, Type: Literature]
View
21
[SID104171220]
 qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749_23, Type: Literature]
View
22
[SID103175225]
 Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins [AID678712, Type: Literature]
View
23
[SID103175225]
 Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins [AID678713, Type: Literature]
View
24
[SID103175225]
 Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins [AID678714, Type: Literature]
View
25
[SID103175225]
 Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins [AID678715, Type: Literature]
View
26
[SID103175225]
 Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins [AID678716, Type: Literature]
View
27
[SID103175225]
 Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins [AID678717, Type: Literature]
View
28
[SID48414314]
 DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results [AID1199, Type: other]
View
29
[SID48414314]
 DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results [AID1205, Type: other]
View
30
[SID48414314]
 DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results [AID1208, Type: other]
View
31
[SID48416423]
 DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database [AID1195, Type: other]
View
32
[SID48414314]
 DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results [AID1189, Type: other]
View
33
[SID56436656]
 Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other]
View
34
[SID855958]
 Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library) [AID841, Type: screening]
View
35
[SID855958]
 Screen for Chemicals that Extend Yeast Lifespan [AID775, Type: screening]
View
36
[SID11109641]
 NINDS Anticonvulsant Data (Qualitative) [AID423, Type: other]
View
37
[SID855958]
 HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening]Estrogen receptor 1 [Homo sapiens] [gi:118764400]
View
38
[SID855958]
 HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening]Estrogen receptor 1 [Homo sapiens] [gi:118764400]
View
39
[SID855958]
 HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening]Estrogen receptor 1 [Homo sapiens] [gi:118764400]
View
40
[SID855958]
 HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors [AID629, Type: screening]Estrogen receptor 1 [Homo sapiens] [gi:118764400]
View
41
[SID103175225]
 Displacement of radiolabeled warfarin from human serum albumin site 1 in phosphate buffer at pH 7.4 upto 12 uM by fluorescence spectroscopy [AID604738, Type: Literature]Serum albumin [gi:113576]
View
42
[SID855958]
 HTS for Estrogen Receptor-beta Coactivator Binding inhibitors [AID633, Type: screening]estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013]
View
43
[SID855958]
 HTS for Estrogen Receptor-beta Coactivator Binding inhibitors [AID633, Type: screening]estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013]
View
44
[SID855958]
 HTS for Estrogen Receptor-beta Coactivator Binding inhibitors [AID633, Type: screening]estrogen receptor beta isoform 1 [Homo sapiens] [gi:10835013]
View
45
[SID855958]
 Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands [AID440, Type: screening]formyl peptide receptor 1 [Homo sapiens] [gi:4503779]
View
46
[SID855958]
 Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands [AID440, Type: screening]formyl peptide receptor 1 [Homo sapiens] [gi:4503779]
View
47
[SID855958]
 Dose Response Assay for Formylpeptide Receptor (FPR) Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands [AID519, Type: confirmatory]formyl peptide receptor 1 [Homo sapiens] [gi:4503779]
View
48
[SID855958]
 Dose Response Assay for Formylpeptide Receptor (FPR) Ligands and Dose Response Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands [AID519, Type: confirmatory]formyl peptide receptor 1 [Homo sapiens] [gi:4503779]
View
49
[SID855958]
 Assay for Formylpeptide Receptor Family Ligands: Target Formylpeptide Receptor [AID805, Type: summary]formyl peptide receptor 1 [Homo sapiens] [gi:4503779]
View
50
[SID855958]
 Assay for Formylpeptide Receptor Family Ligands: Target Formylpeptide Receptor [AID805, Type: summary]formyl peptide receptor 1 [Homo sapiens] [gi:4503779]
View